COPD Research

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Martin R. Stämpfli, PhD, professor in the department of medicine at McMaster University, explains the development of COPD in his lecture at the seminar “COPD—Bridging the Gap between Science and Clinical Care.”

Related Articles
Everyday walking is the most commonly reported problematic daily activity for patients with chronic obstructive pulmonary disease (COPD).
Warfarin remains a cornerstone anticoagulant for a number of reasons that include its low cost at the pharmacy counter.
High hospital readmission rates plague the health care system.
Carmela Avena-Woods, BSPharm, PharmD, CGP, assistant clinical professor of clinical pharmacy practice in the College of Pharmacy and Health Sciences at St. John's University, talks about the importance of individualizing treatment for COPD.
Latest Issues
$auto_registration$